Ultragenyx Pharmaceutical annual gross profit
2017
2018
2022
2023
2024
2025
Ultragenyx Pharmaceutical Gross Profit Growth & History (RARE)
Ultragenyx Pharmaceutical's gross profit was $564.0M for fiscal 2025.
View full Ultragenyx Pharmaceutical company overviewUltragenyx Pharmaceutical annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $564.0M | $81.0M | +16.77% |
| 2024 | 2024-12-31 | $483.0M | $94.0M | +24.16% |
| 2023 | 2023-12-31 | $389.0M | $54.0M | +16.12% |
| 2022 | 2022-12-31 | $335.0M | — | — |
| 2018 | 2018-12-31 | $50.3M | $47.7M | +1828.34% |
| 2017 | 2017-12-31 | $2.6M | — | — |
Ultragenyx Pharmaceutical quarterly gross profit
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $180.0M | $36.0M | +25.00% |
| Q1 2026 | 2026-03-31 | $106.0M | — | — |
| Q4 2025 | 2025-12-31 | $177.9M | — | — |
| Q3 2025 | 2025-09-30 | $131.9M | — | — |
| Q2 2025 | 2025-06-30 | $144.0M | — | — |
| Q2 2019 | 2019-06-30 | $23.4M | $10.7M | +84.80% |
| Q1 2019 | 2019-03-31 | $17.7M | $7.3M | +69.54% |
| Q4 2018 | 2018-12-31 | $15.8M | — | — |
| Q3 2018 | 2018-09-30 | $11.5M | — | — |
| Q2 2018 | 2018-06-30 | $12.7M | — | — |
| Q1 2018 | 2018-03-31 | $10.5M | — | — |
Ultragenyx Pharmaceutical gross profit trends
Between the periods ended 2017-12-31 and 2025-12-31, Ultragenyx Pharmaceutical's gross profit increased from $2.6M to $564.0M, a change of $561.4M. The latest reported quarter, Q2 2026, shows $180.0M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ultragenyx Pharmaceutical source filings ↗